Evaluation of the effect of selective serotonin-reuptake inhibitors on lymphocyte subsets in patients with a major depressive disorder
Authors:
- Daniel Martinez-FongDMDaniel Martinez-Fong
- Mayra Perez-TapiaMPMayra Perez-Tapia
- Iris Estrada-GarciaIEIris Estrada-Garcia
- Sergio Estrada-ParraSESergio Estrada-Parra
- Lenin PavónLenin Pavón
- 1 February 2010
- journal article
- research article
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 20 (2) , 88-95
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Neurotransmitters activate T-cells and elicit crucial functions via neurotransmitter receptorsCurrent Opinion in Pharmacology, 2008
- Neurobiology of depression: an integrated view of key findingsInternational Journal Of Clinical Practice, 2007
- Immune variations in bipolar disorder: phasic differencesBipolar Disorders, 2007
- Neuropharmacology of 5‐hydroxytryptamineBritish Journal of Pharmacology, 2006
- The Effects of Antidepressants on the Hypothalamic-Pituitary-Adrenal AxisDrug News & Perspectives, 2006
- 5-HT1A-mediated promotion of mitogen-activated T and B cell survival and proliferation is associated with increased translocation of NF-κB to the nucleusBrain, Behavior, and Immunity, 2004
- Serotonin Upregulates Mitogen-Stimulated B Lymphocyte Proliferation through 5-HT1AReceptorsCellular Immunology, 1995
- Depression and Immunity: Age, Severity, and Clinical CourseBrain, Behavior, and Immunity, 1993
- Serotonergic 5‐HT1a Receptors Regulate a Cell Contact‐Mediated Interaction between Natural Killer Cells and MonocytesScandinavian Journal of Immunology, 1993
- A RATING SCALE FOR DEPRESSIONJournal of Neurology, Neurosurgery & Psychiatry, 1960